PCH
Polar Capital Holdings Portfolio holdings
AUM
$19.1B
1-Year Return
55.52%
This Quarter Return
+10.79%
1 Year Return
+55.52%
3 Year Return
+234.94%
5 Year Return
–
10 Year Return
–
AUM
$14.6B
AUM Growth
+$951M
(+7%)
Cap. Flow
-$355M
Cap. Flow
% of AUM
-2.44%
Top 10 Holdings %
Top 10 Hldgs %
29.69%
Holding
330
New
34
Increased
99
Reduced
95
Closed
48
Top Buys
| 1 |
McKesson
MCK
|
$137M |
| 2 |
Synopsys
SNPS
|
$134M |
| 3 |
Rambus
RMBS
|
$84M |
| 4 |
NVIDIA
NVDA
|
$84M |
| 5 |
Amazon
AMZN
|
$82.8M |
Top Sells
| 1 |
Microsoft
MSFT
|
$110M |
| 2 |
Teradyne
TER
|
$90.7M |
| 3 |
Apple
AAPL
|
$89.1M |
| 4 |
Visa
V
|
$74.5M |
| 5 |
United Therapeutics
UTHR
|
$72.6M |
Sector Composition
| 1 | Technology | 40.96% |
| 2 | Healthcare | 24.28% |
| 3 | Financials | 16.46% |
| 4 | Communication Services | 8.44% |
| 5 | Consumer Discretionary | 4.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Berkshire Hathaway Class B
BRK.B
$1.09T
| $59.5M | 0.3% |
174,432
-24,652
| -12% | -$8.41M |
|
77
Ryan Specialty Holdings
RYAN
$7.02B
| $59.5M | 0.3% |
1,325,000
| – | – |
|
78
Cloudflare
NET
$73.4B
| $56M | 0.28% |
857,287
-932,789
| -52% | -$61M |
|
79
First American
FAF
$6.74B
| $54.2M | 0.27% |
950,000
| – | – |
|
80
Sanofi
SNY
$111B
| $53.9M | 0.27% |
1,000,000
| – | – |
|
81
Airbnb
ABNB
$76.8B
| $53.2M | 0.27% |
415,009
-296,546
| -42% | -$38M |
|
82
First Solar
FSLR
$21.5B
| $52.4M | 0.26% |
275,765
-54,546
| -17% | -$10.4M |
|
83
Roblox
RBLX
$90.4B
| $51.2M | 0.26% |
1,270,204
-367,127
| -22% | -$14.8M |
|
84
AbbVie
ABBV
$375B
| $48.4M | 0.24% |
358,872
+37,368
| +12% | +$5.03M |
|
85
monday.com
MNDY
$9.37B
| $48.3M | 0.24% |
+282,151
| New | +$48.3M |
|
86
Teradata
TDC
$1.94B
| $48.1M | 0.24% |
+900,299
| New | +$48.1M |
|
87
Analog Devices
ADI
$121B
| $45.8M | 0.23% |
234,964
-207,026
| -47% | -$40.3M |
|
88
Supernus Pharmaceuticals
SUPN
$2.54B
| $45.2M | 0.23% |
1,504,470
+117,055
| +8% | +$3.52M |
|
89
Boston Scientific
BSX
$159B
| $45M | 0.23% |
831,093
-422,848
| -34% | -$22.9M |
|
90
Alnylam Pharmaceuticals
ALNY
$59.1B
| $44.6M | 0.23% |
235,000
-76,918
| -25% | -$14.6M |
|
91
Penumbra
PEN
$10.8B
| $44.2M | 0.22% |
128,556
-832
| -0.6% | -$286K |
|
92
Hagerty
HGTY
$1.14B
| $42.9M | 0.22% |
4,581,705
| – | – |
|
93
Apellis Pharmaceuticals
APLS
$3.56B
| $42.4M | 0.21% |
465,000
| – | – |
|
94
Power Integrations
POWI
$2.5B
| $41.5M | 0.21% |
437,965
+25,802
| +6% | +$2.44M |
|
95
Merit Medical Systems
MMSI
$5.44B
| $40.9M | 0.21% |
488,929
| – | – |
|
96
Elevance Health
ELV
$69.4B
| $39.1M | 0.2% |
87,924
+59,598
| +210% | +$26.5M |
|
97
JPMorgan Chase
JPM
$836B
| $38.2M | 0.19% |
262,389
-55,125
| -17% | -$8.02M |
|
98
Viridian Therapeutics
VRDN
$1.51B
| $38.1M | 0.19% |
1,600,000
+1,050,000
| +191% | +$25M |
|
99
Trip.com Group
TCOM
$47.6B
| $37.9M | 0.19% |
1,083,084
-1,265,806
| -54% | -$44.3M |
|
100
Rhythm Pharmaceuticals
RYTM
$6.85B
| $37.1M | 0.19% |
2,250,000
+500,000
| +29% | +$8.25M |
|